Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin
Abstract Osteosarcoma (OS) is the most common malignant bone tumor and a leading cause of cancer‐related deaths in children and adolescents. Current standard treatments for OS are a combination of preoperative chemotherapy, surgical resection, and adjuvant chemotherapy. Cisplatin is used as the stan...
Saved in:
Main Authors: | Naohiro Oka (Author), Akiyoshi Komuro (Author), Hisayuki Amano (Author), Suman Dash (Author), Masahiko Honda (Author), Kazushige Ota (Author), Shunji Nishimura (Author), Takeshi Ueda (Author), Masao Akagi (Author), Hitoshi Okada (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutropenia induced by cytostatics in oncology
by: Yeris Leydis León Barrios, et al.
Published: (2017) -
Safety monitoring of cytostatic handling
by: Hilda M. Rodríguez Montero, et al.
Published: (2018) -
Fluorouracil and doxorubicin - cardiotoxic cytostatics in the workplace
by: Małgorzata Kupczewska-Dobecka, et al.
Published: (2020) -
Optimisation of maintenance in delivery systems for cytostatic medicines
by: María Carmen Carnero, et al.
Published: (2021) -
Cytostatic and cytotoxic waste - rules of conduct in Poland
by: Marzena Furtak-Niczyporuk, et al.
Published: (2019)